Test Price
30,000 AED✅ Home Collection Available
MiSeq 2x150 bp Paired‑End Sequencing (Flow Cell) – Next-Generation Sequencing Test in UAE
Executive Summary & Core Metrics
Clinical & Regulatory Assurance
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ✓ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-registered Consultant Medical Genetics.
- ✓ Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
Overview
The MiSeq 2x150 bp Paired‑End Sequencing (Flow Cell) is a state‑of‑the‑art next‑generation sequencing (NGS) test that reads both ends of each DNA fragment to deliver ultra‑high‑fidelity genetic data. In the UAE, this assay is used for oncology profiling, anti‑aging risk stratification, and advanced biomedical research, all backed by ISO 9001:2015 certified laboratories and DHA‑compliant protocols.
Methodology Comparison
| Feature | Our Test (MiSeq 2x150 Sequencing) | Closest Alternative (Standard Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity | ~99.5% (limited to single targets) |
| Method | Illumina Sequencing by Synthesis (SBS), paired‑end, 2x150 bp | Capillary electrophoresis (Sanger), low throughput |
| Speed | 2 weeks | 4‑6 weeks for multi‑gene panels |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize that a DNA sequencing report provides a molecular map that must be interpreted within your complete clinical context. This test identifies genetic variants that require careful evaluation by a qualified physician. Please do not self‑interpret genetic findings; always review your results with a licensed specialist.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Genetic test results do not replace ongoing therapeutic decisions.
Exclusion Criteria & Safety Red Flags
- Active chemotherapy within the last 14 days may compromise DNA quality; reschedule after clinical clearance.
- This test is not intended for emergency diagnosis; it requires a stable clinical status.
- Per Federal Decree-Law No. 4 of 2016 on Medical Liability, guardians of minors (under 18) must provide written consent and accompany the patient during specimen collection.
- ER Red Flag: If you experience uncontrolled bleeding, dizziness, or signs of infection at the venipuncture site, seek immediate medical attention.
Patient FAQ & Clinical Guidance
1. What is the MiSeq 2x150 sequencing test used for in clinical practice?
MiSeq 2x150 paired‑end sequencing delivers comprehensive genetic profiling for oncology (somatic mutation detection), anti‑aging risk assessment, and advanced biomedical research. This high‑fidelity assay reads both ends of each DNA fragment to achieve unmatched accuracy, enabling personalized treatment strategies and early risk identification.
2. How should I prepare for the DNA sequencing and what sample is required?
No special fasting is required; we collect either extracted DNA (preferred) or a whole blood sample through our ISO‑certified cold‑chain home service. The phlebotomy team follows strict DHA infection control standards, and you can schedule a visit between 8 AM and 11 PM via WhatsApp.
3. How fast do I receive the results and who will explain them?
Your sequencing results are ready within 2 weeks, accompanied by a DHA‑compliant report that highlights clinically significant variants. A one‑to‑one telephone consultation with a DHA‑licensed genetic specialist is included to guide you through interpretation and next steps.
UAE Regulatory & Data Privacy Adherence
Data Protection & Legal Compliance
This service is fully aligned with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genomic data is encrypted and stored in a Dubai‑based secure server, never shared without explicit consent. The facility holds ISO 9001:2015 Certification (INT/EGQ/2509DA/3139) and operates under DHA Facility License No. 1143. Clinical safety and consent procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | MiSeq 2x150 bp Paired‑End Sequencing (Flow Cell) |
| Price (AED) | 30,000 AED |
| Turnaround Time | 2 weeks |
| Sample Type / Matrix | Extracted DNA or Whole Blood (EDTA) |
| Methodology Used | Illumina Sequencing by Synthesis (SBS), Paired‑End, 2x150 bp |
| ICD-10-CM Code | Z01.81 |
| LOINC Code | 92822-6 |
| DHA Facility License & Laboratory Address Invariants | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians